Advertisements


We are Sorry, This Page doesn't Exist


Akero Therapeutics announces expansion of Phase 2a BALANCED study of AKR-001

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: smallbizSource: nytJan 13th, 2020

EyeGate announces additional data from PRK study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: worldSource: nytDec 2nd, 2019

Valeritas announces additional V-Go data from Verdict study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 15th, 2019

Celsion announces data lock for interim analysis in OPTIMA Phase III study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 5th, 2019

Celgene announces updated analysis of data from Phase 2 JAKARTA2 clinical study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 3rd, 2019

Takeda announces new data from ad-hoc analysis of Phase 3 HELP Study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 3rd, 2019

Valeritas announces additional data from VERDICT study at ISPOR

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 22nd, 2019

Pfizer announces presentation of data from Phase 2 study of 20vPnC candidate

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 14th, 2019

Altimmune announces additional data from phase 2 NasoVAX study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 19th, 2019

Roche Announces Positive Data on Gazyva and MS Drug Ocrevus

Roche (RHHBY) announced positive long-term data on leukemia drug Gazyva and MS drug Ocrevus. Roche RHHBY announced encouraging data from the final analysis of the CLL11 study, evaluating Gazyva-based treatment in previously untreated.....»»

Category: smallbizSource: nytJun 15th, 2018

DBV announces additional Phase I data in pertussis toxin study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 5th, 2018

Oncorus announces publication of preclinical data on ONCR-177 study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 20th, 2021

Leading BioSciences announces topline data from gastrointestinal surgery study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 8th, 2021

RedHill Biopharma announces safety, efficacy data from Phase 2 COVID-19 study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 31st, 2020

Inovio announces publication of Phase 1 data from study of INO-4800

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 24th, 2020

Kiniksa announces data from U.S. investigator-initiated study of mavrilimumab

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 22nd, 2020

Cytokinetics announces additional data from FORTITUDE-ALS trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 14th, 2020

Ultragenyx announces data from confirmatory cohort of Phase 1/2 study of DTX401

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 15th, 2020

Celsion says Phase III OPTIMA study on track for interim data analysis in July

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 15th, 2020

Frequency Therapeutics announces data from FX-322 exploratory clinical study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 14th, 2020